✦ LIBER ✦

Long-term results of intravesical chemoprophylaxis of superficial bladder cancer: experience of the Japanese urological cancer research group for Adriamycin

✍ Scribed by Hideyuki Akaza; Kenkichi Koiso; Toshihiko Kotake; Yosuke Matsumura; Shigeo Isaka; Toyohei Machida; Koji Obata; Yasuo Ohashi; Hiroshi Ohe; Yoshitada Ohi; Jun Shimazaki; Kazuya Tashiro; Toyofumi Ueda; Susumu Kagawa; Tadao Niijima

Publisher: Springer
Year: 1992
Tongue: English
Weight: 570 KB
Volume: 30
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00686935

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The 4th study of prophylactic intravesic

The 4th study of prophylactic intravesical chemotherapy with Adriamycin in the treatment of superficial bladder cancer: the experience of the Japanese urological cancer research group of Adriamycin

✍ Yosuke Matsumura; Hideyuki Akaza; Shigeo Isaka; Susumu Kagawa; Kenkichi Koiso; T 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 397 KB

Intravesical therapy with adriamycin and

Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group

✍ A. P. M. van der Meijden; Karl-Heinz Kurth; Wim Oosterlinck; Frans M. J. Debruyn 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 387 KB

Intravesical chemotherapy for maximum pr

Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection : A combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function

✍ Shiro Hinotsu; Hideyuki Akaza; Yasuo Ohashi; Toshihiko Kotake 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## BACKGROUND. The effect of intravesical instillation of doxorubicin or epirubicin after transurethral resection (TUR) was estimated from the data of five randomized clinical trials in Japan. The authors provided the estimated hazard function plots with a smoothing technique, to evaluate the prop

Phase III trial of The Japanese Urologic

Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder

✍ Akio Maru; Hideyuki Akaza; Shigeo Isaka; Kenkichi Koiso; Toshihiko Kotake; Toyoh 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 489 KB

Long-term prophylactic effects of intrav

Long-term prophylactic effects of intravesical instillation of thiotepa and oral administration of UFT on the recurrence of superficial bladder cancer after transurethral resection

✍ S. Tabata; Seiichiro Ozono; Yoshihiko Hirao; Kenji Takashima; Kenji Sasaki; Shuj 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 78 KB

Sequential vinorelbine–capecitabine foll

Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial

✍ Marwan Ghosn; Joseph Kattan; Fadi Farhat; Fariha Younes; Fadi Nasr; Walid Moukad 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 307 KB